BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27881740)

  • 1. Peripheral self-reactivity regulates antigen-specific CD8 T-cell responses and cell division under physiological conditions.
    Swee LK; Tan ZW; Sanecka A; Yoshida N; Patel H; Grotenbreg G; Frickel EM; Ploegh HL
    Open Biol; 2016 Nov; 6(11):. PubMed ID: 27881740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103
    Sanecka A; Yoshida N; Kolawole EM; Patel H; Evavold BD; Frickel EM
    Front Immunol; 2018; 9():1290. PubMed ID: 29922298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare population of tumor antigen-specific CD4
    Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
    J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute-phase Toxoplasma gondii burden.
    Sanecka A; Yoshida N; Dougan SK; Jackson J; Shastri N; Ploegh H; Blanchard N; Frickel EM
    Immunology; 2016 Nov; 149(3):270-279. PubMed ID: 27377596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative, single-cell PCR analysis of an antigen-specific TCR repertoire selected during an in vivo CD8 response: direct evidence for a wide range of clone sizes with uniform tissue distribution.
    Maryanski JL; Attuil V; Bucher P; Walker PR
    Mol Immunol; 1999 Aug; 36(11-12):745-53. PubMed ID: 10593513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
    Kondo K; Fujiki F; Nakajima H; Yatsukawa E; Morimoto S; Tatsumi N; Nishida S; Nakata J; Oka Y; Tsuboi A; Hosen N; Oji Y; Sugiyama H
    J Immunother; 2016 Apr; 39(3):127-39. PubMed ID: 26938946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.
    Flerin NC; Chen H; Glover TD; Lamothe PA; Zheng JH; Fang JW; Ndhlovu ZM; Newell EW; Davis MM; Walker BD; Goldstein H
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells.
    Montoya JG; Lowe KE; Clayberger C; Moody D; Do D; Remington JS; Talib S; Subauste CS
    Infect Immun; 1996 Jan; 64(1):176-81. PubMed ID: 8557337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro model of T cell receptor revision in mature human CD8+ T cells.
    Lantelme E; Orlando L; Porcedda P; Turinetto V; De Marchi M; Amoroso A; Mantovani S; Giachino C
    Mol Immunol; 2008 Jan; 45(2):328-37. PubMed ID: 17659780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors.
    Verdeil G; Puthier D; Nguyen C; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2006 Apr; 176(8):4834-42. PubMed ID: 16585578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of secondary TCR engagement on the heterogeneity of pathogen-specific CD8+ T cell response during acute and chronic toxoplasmosis.
    Shallberg LA; Phan AT; Christian DA; Perry JA; Haskins BE; Beiting DP; Harris TH; Koshy AA; Hunter CA
    PLoS Pathog; 2022 Jun; 18(6):e1010296. PubMed ID: 35727849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
    Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
    Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity.
    Shamim M; Nanjappa SG; Singh A; Plisch EH; LeBlanc SE; Walent J; Svaren J; Seroogy C; Suresh M
    J Immunol; 2007 Dec; 179(11):7233-43. PubMed ID: 18025165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite.
    Feliu V; Vasseur V; Grover HS; Chu HH; Brown MJ; Wang J; Boyle JP; Robey EA; Shastri N; Blanchard N
    PLoS Pathog; 2013; 9(6):e1003449. PubMed ID: 23818852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.